Synapse - Taha Merghoub

Results (14)

Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer

Journal Article

Memon, D.; Schoenfeld, A. J.; Ye, D.; Fromm, G.; Rizvi, H.; Zhang, X.; Keddar, M. R.; Mathew, D.; Yoo, K. J.; Qiu, J.; more...
Cancer Cell (2024)

Fulltext@MSK | Save

Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade

Journal Article

Pai, J. A.; Hellmann, M. D.; Sauter, J. L.; Mattar, M.; Rizvi, H.; Woo, H. J.; Shah, N.; Nguyen, E. M.; Uddin, F. Z.; Quintanal-Villalonga, A.; more...
Cancer Cell (2023)

Fulltext@MSK | Save

The ectonucleotidase CD39 identifies tumor-reactive CD8(+) T cells predictive of immune checkpoint blockade efficacy in human lung cancer

Journal Article

Chow, A.; Uddin, F. Z.; Liu, M.; Dobrin, A.; Nabet, B. Y.; Mangarin, L.; Lavin, Y.; Rizvi, H.; Tischfield, S. E.; Quintanal-Villalonga, A.; more...
Immunity (2023)

Fulltext@MSK | Save

Immunotherapy-mediated thyroid dysfunction: Genetic risk and impact on outcomes with PD-1 blockade in non-small cell lung cancer

Journal Article

Luo, J.; Martucci, V. L.; Quandt, Z.; Groha, S.; Murray, M. H.; Lovly, C. M.; Rizvi, H.; Egger, J. V.; Plodkowski, A. J.; Abu-Akeel, M.; more...
Clinical Cancer Research (2021)

Fulltext@MSK | Save

Tim-4(+) cavity-resident macrophages impair anti-tumor CD8(+) T cell immunity

Journal Article

Chow, A.; Schad, S.; Green, M. D.; Hellmann, M. D.; Allaj, V.; Ceglia, N.; Zago, G.; Shah, N. S.; Sharma, S. K.; Mattar, M.; more...
Cancer Cell (2021)

Fulltext@MSK | Save

Strategies to improve the sensitivity and ranking ability of neoantigen prediction methods: Report on the results of the Tumor nEoantigen SeLection Alliance (TESLA)

Meeting Abstract

Wells, D. K.; Dang, K.; Hubbard-Lucey, V. M.; Sheehan, K. C.; Lamb, A.; Ward, J. P.; Sidney, J.; Blazquez, A. B.; Rech, A. J.; Zaretsky, J.; more...
Cancer Research (2020)

Fulltext@MSK | Save

A noninvasive approach for early prediction of therapeutic benefit from immune checkpoint inhibition for lung cancer

Meeting Abstract

Nabet, B. Y.; Esfahani, M. S.; Hamilton, E. G.; Chabon, J. J.; Moding, E. J.; Rizvi, H.; Steen, C. B.; Chaudhuri, A. A.; Liu, C. L.; Hui, A. B.; more...
Cancer Research (2020)

Fulltext@MSK | Save

Tim-4(+) resident macrophages impair anti-tumor immunity in the serous body cavities by sequestering viable and cytotoxic CD8(+) T cells expressing high levels of phosphatidylserine

Meeting Abstract

Chow, A.; Schad, S.; Green, M.; Hellmann, M.; Ceglia, N.; Allaj, V.; Zago, G.; Shah, N.; Sharma, S.; Mattar, M.; more...
Journal for ImmunoTherapy of Cancer (2020)

Fulltext@MSK | Save

Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction

Journal Article

Wells, D. K.; van Buuren, M. M.; Dang, K. K.; Hubbard-Lucey, V. M.; Sheehan, K. C. F.; Campbell, K. M.; Lamb, A.; Ward, J. P.; Sidney, J.; Blazquez, A. B.; more...
Cell (2020)

Fulltext@MSK | Save

Noninvasive early identification of therapeutic benefit from immune checkpoint inhibition

Journal Article

Nabet, B. Y.; Esfahani, M. S.; Moding, E. J.; Hamilton, E. G.; Chabon, J. J.; Rizvi, H.; Steen, C. B.; Chaudhuri, A. A.; Liu, C. L.; Hui, A. B.; more...
Cell (2020)

Fulltext@MSK | Save